2009ContraceptionRequires access

A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom® formulations in Cameroonian women

François‐Xavier Mbopi‐Kéou, Sylvie Trottier, Rabeea F. Omar, Ngoh N. Nkele, Séraphin Fokoua, Enow Robinson Mbu, Marc-Christian Domingo, Jean‐François Giguère, Jocelyne Piret, Anthony Mwatha, Benoı̂t Mâsse, Michel G. Bergeron

Open publisher page 26 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Microbicide, Medicine, Microbicides for sexually transmitted diseases, Placebo, Vaginal microbicide, Intravaginal administration, Condom, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom® formulations in Cameroonian women — Research Paper | ScholarLens